Cardinal motor features of Parkinson's disease (PD) include bradykinesia, rest tremor, and
rigidity, which appear in the early stages of the disease and largely depend on …

Background: Alzheimer's disease (AD) and dementia are chronic diseases with progressive
deterioration of cognition, function, and behavior leading to severe disability and death. The …

Substance use disorders (SUDs) are characterized by a recurrent and maladaptive use of
drugs and/or alcohol. Cognitive behavioral therapies (CBTs) comprise different types of …

The current COVID-19 pandemic presents unprecedented new challenges to public health
and medical care delivery. To control viral transmission, social distancing measures have …

SARS-CoV-2 survivors may report persistent symptoms that resemble myalgic
encephalomyelitis/chronic fatigue syndrome (ME/CFS). We explored (a) ME/CFS-like …

Neuropsychological testing is a key diagnostic tool for assessing people with dementia and
mild cognitive impairment, but can also help in other neurological conditions such as …

Mild cognitive impairment (MCI) and chemosensory dysfunction are non-motor symptoms of
Parkinson's disease (PD), but their association is unclear. We explored if MCI and the …

Cognitive and physical activity treatments (CT and PT) are two non-pharmacological
approaches frequently used in patients with Mild Cognitive Impairment (MCI) and …

Benzodiazepines (BZDs) are the most widely prescribed drug class in developed countries,
but they have high potential for tolerance, dependence and abuse. Cognitive deficits in long …

Benzodiazepines (BZDs) are among the most widely prescribed drugs in developed
countries, but they have a high potential for tolerance, dependence and misuse. High-dose …